Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 1201 to 1250 of 2555

TitleReference numberPublishedLast updated
Lenalidomide plus dexamethasone for multiple myeloma after 1 treatment with bortezomibTA586
Lenalidomide plus dexamethasone for previously untreated multiple myelomaTA587
Depression in children and young people: identification and managementNG134
Urinary incontinence and pelvic organ prolapse in women: managementNG123
Ambu aScope4 Broncho for use in unexpected difficult airwaysHTG312
Percutaneous mechanical thrombectomy for acute deep vein thrombosis of the legHTG516
Bronchoscopic thermal vapour ablation for upper-lobe emphysemaHTG517
Percutaneous insertion of a cerebral protection device to prevent cerebral embolism during TAVIHTG515
Ocrelizumab for treating primary progressive multiple sclerosisTA585
Endocuff Vision for assisting visualisation during colonoscopyHTG514
Physical activity: encouraging activity in the communityQS183
Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetesTA583
Atezolizumab in combination for treating metastatic non-squamous non-small-cell lung cancerTA584
The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central cathetersHTG368
Therapeutic hypothermia for acute ischaemic strokeHTG511
Collagen paste for closing an anal fistulaHTG512
Percutaneous mitral valve leaflet repair for mitral regurgitationHTG513
Hyperparathyroidism (primary): diagnosis, assessment and initial managementNG132
Enzalutamide for hormone-relapsed non-metastatic prostate cancerTA580
Curos for preventing infections when using needleless connectorsHTG510
DuraGraft for preserving vascular graftsMIB184
Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary careHTG508
Crohn's disease: managementNG129
Ulcerative colitis: managementNG130
Intrapartum care for women with existing medical conditions or obstetric complications and their babiesNG121
Brentuximab vedotin for treating CD30-positive cutaneous T-cell lymphomaTA577
Endoscopic ablation for an anal fistulaHTG506
Endoscopic ablation for a pilonidal sinusHTG507
Certolizumab pegol for treating moderate to severe plaque psoriasisTA574
Tildrakizumab for treating moderate to severe plaque psoriasisTA575
Bosutinib for untreated chronic myeloid leukaemia (terminated appraisal)TA576
ADXBLADDER for detecting bladder cancerMIB180
Specialist neonatal respiratory care for babies born pretermNG124
Narrow band imaging for Barrett's oesophagusMIB179
Ertugliflozin as monotherapy or with metformin for treating type 2 diabetesTA572
The Debrisoft monofilament debridement pad for use in acute or chronic woundsHTG334
Pertuzumab for adjuvant treatment of HER2-positive early stage breast cancerTA569
Pembrolizumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy (terminated appraisal)TA570
Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinibTA571
Kendall DL for ECG monitoring in people having cardiac surgeryMIB177
Radially emitting laser fibre treatment of an anal fistulaHTG505
Abatacept for treating psoriatic arthritis after DMARDs (terminated appraisal)TA568
Cochlear implants for children and adults with severe to profound deafnessTA566
CADScor system for ruling out coronary artery disease in people with symptoms of stable coronary artery diseaseMIB174
Prevena incision management system for closed surgical incisionsMIB173
Air pollution: outdoor air quality and healthQS181
People's experience using adult social care servicesQS182
High-intensity focused ultrasound for symptomatic benign thyroid nodulesHTG504
Venetoclax with rituximab for previously treated chronic lymphocytic leukaemiaTA561
Encorafenib with binimetinib for unresectable or metastatic BRAF V600 mutation-positive melanomaTA562

Results per page

  1. 10
  2. 25
  3. 50
  4. All